James Kelbert , Rishika Bhojanapalli , Gilberto Perez Rodriguez Garcia , Dana Saleh , Rosa Araujo , Ganesh Murthy , Robert W Bina
{"title":"Genetic and molecular markers of cortical brain biopsy in idiopathic normal pressure Hydrocephalus: A scoping review","authors":"James Kelbert , Rishika Bhojanapalli , Gilberto Perez Rodriguez Garcia , Dana Saleh , Rosa Araujo , Ganesh Murthy , Robert W Bina","doi":"10.1016/j.inat.2025.102118","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Idiopathic normal pressure hydrocephalus (iNPH) is a condition classically defined by the triad of gait disturbance, cognitive dysfunction, and urinary incontinence. While categorized under the umbrella of cognitive and gait disorders, there is no clear consensus about its molecular etiology. Brain biopsies showing the presence of specific aggregated proteins have been suggested as a potential indicator of iNPH pathophysiology. This review summates existing literature for potential iNPH biomarkers from cortical brain tissue.</div></div><div><h3>Methodology</h3><div>A scoping review was conducted according to PRISMA guidelines. The terms “cortical biopsy” and “normal pressure hydrocephalus” were searched on December 14th, 2023 using PubMed, EMBASE and Scopus databases. All articles were screened by two independent reviewers. Data were manually collected after quality assessment and tabulated.</div></div><div><h3>Results</h3><div>Twenty-one articles were included in this study. Alzheimer’s-related biomarkers were most commonly reported from brain biopsies of iNPH patients, including various types of amyloid-beta, neuritic plaques, neurofibrillary tangles, and phosphorylated tau. Amyloid-beta and phosphorylated tau were the most reported from patient cortical biopsies and attenuated levels of these biomarkers were associated with better shunt placement outcomes. Other biomarkers included several interleukins, interferons, dystrophin proteins, glial fibrillary acidic protein (GFAP), glycoproteins, and aquaporins. Increased levels of GFAP, leucine-rich-alpha-2-glycoprotein, and gamma-secretase were associated with iNPH along with decreased levels of aquaporin-4 and dystrophin protein-71.</div></div><div><h3>Conclusion</h3><div>Amyloid pathology is the most reported potential biomarker for iNPH patients. Second most common are markers associated with water homeostasis. Along with further exploration of other non-amyloid molecular markers, these findings could be used in the creation of animal models for further investigation.</div></div>","PeriodicalId":38138,"journal":{"name":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","volume":"42 ","pages":"Article 102118"},"PeriodicalIF":0.5000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214751925001306","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Idiopathic normal pressure hydrocephalus (iNPH) is a condition classically defined by the triad of gait disturbance, cognitive dysfunction, and urinary incontinence. While categorized under the umbrella of cognitive and gait disorders, there is no clear consensus about its molecular etiology. Brain biopsies showing the presence of specific aggregated proteins have been suggested as a potential indicator of iNPH pathophysiology. This review summates existing literature for potential iNPH biomarkers from cortical brain tissue.
Methodology
A scoping review was conducted according to PRISMA guidelines. The terms “cortical biopsy” and “normal pressure hydrocephalus” were searched on December 14th, 2023 using PubMed, EMBASE and Scopus databases. All articles were screened by two independent reviewers. Data were manually collected after quality assessment and tabulated.
Results
Twenty-one articles were included in this study. Alzheimer’s-related biomarkers were most commonly reported from brain biopsies of iNPH patients, including various types of amyloid-beta, neuritic plaques, neurofibrillary tangles, and phosphorylated tau. Amyloid-beta and phosphorylated tau were the most reported from patient cortical biopsies and attenuated levels of these biomarkers were associated with better shunt placement outcomes. Other biomarkers included several interleukins, interferons, dystrophin proteins, glial fibrillary acidic protein (GFAP), glycoproteins, and aquaporins. Increased levels of GFAP, leucine-rich-alpha-2-glycoprotein, and gamma-secretase were associated with iNPH along with decreased levels of aquaporin-4 and dystrophin protein-71.
Conclusion
Amyloid pathology is the most reported potential biomarker for iNPH patients. Second most common are markers associated with water homeostasis. Along with further exploration of other non-amyloid molecular markers, these findings could be used in the creation of animal models for further investigation.